The $3.30 central target is calculated from six attributable, current analyst price targets. At the cautious end, BofA Securities holds a $1.75 target (November 9, 2026), and RBC Capital downgraded the stock to Underperform with a $2.00 target (October 30, 2026). Exane BNP Paribas moved to a Hold with a $2.25 target, while Wells Fargo carries a $3.80 target. At the bullish end, Maxim Group and Colliers Securities each hold $5.00 targets. The resulting low-to-high range of $1.75 to $5.00 is exceptionally wide, and the average analyst price target of $3.30 sits above the current price by a large margin but well below the high end of the range.
The rationale diverges sharply. Bears cite missed rent payments from tenant HSA, limited visibility into when collections resume, and a tight liquidity position. Bulls argue the shares already discount severe distress and that stabilized cash flows would support a material re-rating. Several recent actions were downgrades and target cuts rather than upgrades, which is an important signal about near-term sentiment even though the average target remains elevated. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At roughly $1.75 per share, reaching $3.30 would require an advance of about 88%, which is a very large move for a large-cap healthcare REIT and would imply a near-doubling from current levels. The shares have already fallen far from a 52-week high of about $6.47, and the 52-week low is near $1.48, so the stock is trading close to the bottom of its recent range. In my view, this positioning leaves little room for further downside surprises if fundamentals stabilize.
The path toward the target would most likely depend on restoring tenant rent collections, demonstrating progress on debt refinancing, and rebuilding investor confidence in the sustainability of the dividend. The company reported third-quarter revenue below consensus expectations, and normalized FFO (funds from operations) declined year over year, partly reflecting HSA's missed September rent payment. Until those cash-flow concerns are resolved, the valuation is likely to remain discounted relative to the average analyst price target.
The stock is trading near its 52-week low around $1.48, with the $2.00 mark representing both a nearby psychological level and the area of several recent bearish targets. Resistance is likely to emerge first near $2.00 to $2.25, then around $3.80 where Wells Fargo's target sits. A durable recovery would require the shares to reclaim and hold above these zones, while a break below $1.48 would mark a new multi-year low and signal further downside pressure. From what I see, these levels warrant close attention in the coming weeks.
Analyst price targets generally reflect a research horizon of roughly twelve months, though individual firms may vary. Investors should watch tenant rent-collection updates, refinancing announcements, changes to the dividend, and any new analyst target revisions or rating changes. Upcoming quarterly earnings and FFO reports will be central to whether the bearish or bullish case gains traction, alongside broader interest-rate conditions that affect REIT valuations.
In my trading routine, I have found Tickeron’s AI Daily Buy/Sell Signals helpful for monitoring momentum shifts in names like MPT. The tool scans thousands of securities in real time and flags Buy, Sell, or Hold signals based on technical and market-condition changes. This can complement fundamental work when assessing whether a recovery toward $3.30 is gaining traction or facing renewed pressure.
Can MPT reach $3.30? The figure is a calculated average of six current analyst targets, not a guarantee, and the wide $1.75-to-$5.00 range shows how divided Wall Street remains. Reaching the target would require an advance of roughly 88%, a very large move that hinges on restoring tenant rent collections, shoring up liquidity, and proving the dividend is sustainable. Bears point to missed rent payments and recent downgrades; bulls argue the distressed valuation already reflects those fears. Investors should watch tenant updates, refinancing progress, and analyst revisions rather than treating the average target as a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 41 cases where MPT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 73%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MPT's RSI Indicator exited the oversold zone, 22 of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 57 cases where MPT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for MPT just turned positive on November 19, 2026. Looking at past instances where MPT's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
Following a +7.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where MPT advanced for three days, in 164 of 239 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for MPT entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.240) is normal, around the industry mean (3.134). MPT has a moderately low P/E Ratio (-36.200) as compared to the industry average of (30.791). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.649). MPT's Dividend Yield (0.199) is considerably higher than the industry average of (0.050). P/S Ratio (1.994) is also within normal values, averaging (6.013).
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. MPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PublishingBooksMagazines